Yes, m123456, there's a long way to go before results from Phase...

Yes, m123456, there's a long way to go before results from Phase 2, and then there's Phase 3. If Phase 2 is successful there will certainly be a major jump then, but it's a long way off. I was also in this stock since well before the Imagine trial went belly up, and people are getting excited about a stock that crashed out from $1.20 then (2013) and has never been much above 10c (from memory) since then, apart from this week of course. I agree with you that PBT2 was and still is the most promising drug to come along for Alzheimers, but the FDA put the kybosh on that when they insisted on going back to dog trials, even after it had been proven again and again to be safe for humans (big pharma influence, maybe?). I pulled the plug this week at 16.5 cents, but may re-enter if the price drops below 3 cents after close of CR. I lost big time on this one, but over the years have managed to offset most of the losses against profits from other stocks (AKP was my biggie!). Good luck to all, and newbies - treat this one with great care!